Jun Iwanami

3.0k citations

78 papers · 2.5k indexed · h-index 31

Impact in

Neurology top 2%
- Neuroinflammation and Neurodegeneration Mechanisms
- Neurological Disease Mechanisms and Treatments
Cardiology and Cardiovascular Medicine top 2%
- Renin-Angiotensin System Studies
- Blood Pressure and Hypertension Studies

Papers in ⓘ

Neurology 25
- Neuroinflammation and Neurodegeneration Mechanisms 16
- Neurological Disease Mechanisms and Treatments 11
Cardiology and Cardiovascular Medicine 30
- Renin-Angiotensin System Studies 26

Co-authors: Masatsugu Horiuchi (69 shared papers)Masaki Mogi (68 shared papers)Li‐Juan Min (53 shared papers)Kana Tsukuda (53 shared papers)Masaru Iwai (22 shared papers)Akiko Sakata (18 shared papers)Jian‐Mei Li (11 shared papers)Fei Jing (16 shared papers)
Journals: Hypertension (12 papers)Hypertension Research (7 papers)PLoS ONE (7 papers)Journal of the American Society of Hypertension (6 papers)American Journal of Hypertension (5 papers)
Partner nations: Japan Sweden Germany

In The Last Decade

Jun Iwanami

74 papers receiving 2.5k citations

Peers

Countries citing papers authored by Jun Iwanami

Since Specialization

Citations

This map shows the geographic impact of Jun Iwanami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Iwanami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Iwanami more than expected).

Fields of papers citing papers by Jun Iwanami

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Iwanami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Iwanami. The network helps show where Jun Iwanami may publish in the future.

Co-authors

The 25 scholars most cited alongside Jun Iwanami, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jun Iwanami Line = papers co-authored together Jun Iwanami links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 78 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Cognitive Deficit in Amyloid-β–Injected Mice Was Improved by Pretreatment With a Low Dose of Telmisartan Partly Because of Peroxisome Proliferator-Activated Receptor-γ Activation Hypertension ·Kana Tsukuda, Masaki Mogi, Jun Iwanami, Li‐Juan Min, Akiko Sakata, Fei Jing, Masaru Iwai, Masatsugu Horiuchi	2009	161
2	Aldosterone and Angiotensin II Synergistically Induce Mitogenic Response in Vascular Smooth Muscle Cells Circulation Research ·Li‐Juan Min, Masaki Mogi, Jian‐Mei Li, Jun Iwanami, Masaru Iwai, Masatsugu Horiuchi	2005	146
3	Telmisartan prevented cognitive decline partly due to PPAR-γ activation Biochemical and Biophysical Research Communications ·Masaki Mogi, Jian‐Mei Li, Kana Tsukuda, Jun Iwanami, Li‐Juan Min, Akiko Sakata, Teppei Fujita, Masaru Iwai, Masatsugu Horiuchi	2008	116
4	Cross-talk between aldosterone and angiotensin II in vascular smooth muscle cell senescence Cardiovascular Research ·Min Li, Masayuki Mogi, Jun Iwanami, Jiali Li, Akiko Sakata, Takeshi Fujita, Kana Tsukuda, Masako Iwai, M HORIUCHI	2007	89
5	Angiotensin II Type-2 Receptor Stimulation Prevents Neural Damage by Transcriptional Activation of Methyl Methanesulfonate Sensitive 2 Hypertension ·Masaki Mogi, Jian‐Mei Li, Jun Iwanami, Li‐Juan Min, Kana Tsukuda, Masaru Iwai, Masatsugu Horiuchi	2006	89
6	Peroxisome Proliferator-Activated Receptor-γ Activation With Angiotensin II Type 1 Receptor Blockade Is Pivotal for the Prevention of Blood-Brain Barrier Impairment and Cognitive Decline in Type 2 Diabetic Mice Hypertension ·Li‐Juan Min, Masaki Mogi, Masachika Shudou, Fei Jing, Kana Tsukuda, Kousei Ohshima, Jun Iwanami, Masatsugu Horiuchi	2012	89
7	Direct Stimulation of Angiotensin II Type 2 Receptor Enhances Spatial Memory Journal of Cerebral Blood Flow & Metabolism ·Jing Fei, Masaki Mogi, Akiko Sakata, Jun Iwanami, Kana Tsukuda, Kousei Ohshima, Li‐Juan Min, U. Muscha Steckelings, Thomas Unger, Björn Dahlöf, Masatsugu Horiuchi	2011	80
8	Angiotensin II-Induced Neural Differentiation via Angiotensin II Type 2 (AT₂) Receptor-MMS2 Cascade Involving Interaction between AT₂Receptor-Interacting Protein and Src Homology 2 Domain-Containing Protein-Tyrosine Phosphatase 1 Molecular Endocrinology ·Jian‐Mei Li, Masaki Mogi, Kana Tsukuda, Hirokazu Tomochika, Jun Iwanami, Li‐Juan Min, Clara Nahmias, Masaru Iwai, Masatsugu Horiuchi	2006	76
9	Roles of Brain Angiotensin II in Cognitive Function and Dementia International Journal of Hypertension ·Masaki Mogi, Jun Iwanami, Masatsugu Horiuchi	2012	71
10	Regulation of angiotensin II receptors beyond the classical pathway Clinical Science ·Masatsugu Horiuchi, Jun Iwanami, Masaki Mogi	2012	71
11	Administration of bovine casein-derived peptide prevents cognitive decline in Alzheimer disease model mice PLoS ONE ·Li‐Juan Min, Yodai Kobayashi, Masaki Mogi, Kana Tsukuda, Akio Yamada, Koji Yamauchi, Fumiaki Abe, Jun Iwanami, Jin‐zhong Xiao, Masatsugu Horiuchi	2017	66
12	Deficiency of angiotensin-converting enzyme 2 causes deterioration of cognitive function PubMed ·Xiaoli Wang, Jun Iwanami, Li‐Juan Min, Kana Tsukuda, Hirotomo Nakaoka, Hui‐Yu Bai, Bao‐Shuai Shan, Harumi Kan‐no, Masayoshi Kukida, Toshiyuki Chisaka, Toshifumi Yamauchi, Akinori Higaki, Masaki Mogi, Masatsugu Horiuchi	2016	65
13	Possible Role of Angiotensin-Converting Enzyme 2 and Activation of Angiotensin II Type 2 Receptor by Angiotensin-(1–7) in Improvement of Vascular Remodeling by Angiotensin II Type 1 Receptor Blockade Hypertension ·Kousei Ohshima, Masaki Mogi, Hirotomo Nakaoka, Jun Iwanami, Li‐Juan Min, Harumi Kan‐no, Kana Tsukuda, Toshiyuki Chisaka, Hui‐Yu Bai, Xiaoli Wang, Akiyoshi Ogimoto, Jitsuo Higaki, Masatsugu Horiuchi	2013	64
14	Direct Angiotensin II Type 2 Receptor Stimulation Ameliorates Insulin Resistance in Type 2 Diabetes Mice with PPARγ Activation PLoS ONE ·Kousei Ohshima, Masaki Mogi, Fei Jing, Jun Iwanami, Kana Tsukuda, Li‐Juan Min, Akiyoshi Ogimoto, Björn Dahlöf, U. Muscha Steckelings, Tomas Unger, Jitsuo Higaki, Masatsugu Horiuchi	2012	60
15	Direct Stimulation of Angiotensin II Type 2 Receptor Initiated After Stroke Ameliorates Ischemic Brain Damage American Journal of Hypertension ·Li‐Juan Min, Masaki Mogi, Kana Tsukuda, Fei Jing, Kousei Ohshima, Hirotomo Nakaoka, Harumi Kan‐no, Xiaoli Wang, Toshiyuki Chisaka, Hui‐Yu Bai, Jun Iwanami, Masatsugu Horiuchi	2014	56
16	Low dose of telmisartan prevents ischemic brain damage with peroxisome proliferator-activated receptor-γ activation in diabetic mice Journal of Hypertension ·Jun Iwanami, Masaki Mogi, Kana Tsukuda, Li‐Juan Min, Akiko Sakata, Jing Fei, Masaru Iwai, Masatsugu Horiuchi	2010	53
17	Roles of Interleukin 17 in Angiotensin II Type 1 Receptor–Mediated Insulin Resistance Hypertension ·Kousei Ohshima, Masaki Mogi, Fei Jing, Jun Iwanami, Kana Tsukuda, Li‐Juan Min, Jitsuo Higaki, Masatsugu Horiuchi	2011	48
18	Inhibition of the renin–angiotensin system and target organ protection Hypertension Research ·Jun Iwanami, Masaki Mogi, Masaru Iwai, Masatsugu Horiuchi	2009	46
19	Diabetes-Associated Cognitive Impairment Is Improved by a Calcium Channel Blocker, Nifedipine Hypertension ·Kana Tsukuda, Masaki Mogi, Jian‐Mei Li, Jun Iwanami, Li‐Juan Min, Akiko Sakata, Teppei Fujita, Masaru Iwai, Masatsugu Horiuchi	2008	45
20	Sex-different effect of angiotensin II type 2 receptor on ischemic brain injury and cognitive function Brain Research ·Akiko Sakata, Masaki Mogi, Jun Iwanami, Kana Tsukuda, Li‐Juan Min, Teppei Fujita, Masaru Iwai, Masaharu Ito, Masatsugu Horiuchi	2009	41

About Jun Iwanami

Jun Iwanami is a scholar working on Neurology, Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Biochemistry and Molecular Biology, having authored 78 papers that have together received 2.5k indexed citations. Recurring topics across this work include Renin-Angiotensin System Studies (26 papers), Receptor Mechanisms and Signaling (19 papers), Neuroinflammation and Neurodegeneration Mechanisms (16 papers), Hormonal Regulation and Hypertension (13 papers), Neurological Disease Mechanisms and Treatments (11 papers), Peroxisome Proliferator-Activated Receptors (5 papers), Cardiovascular, Neuropeptides, and Oxidative Stress Research (5 papers) and Adipokines, Inflammation, and Metabolic Diseases (5 papers). The work is most often cited by research in Neurology (421 citations), Cardiology and Cardiovascular Medicine (1.0k citations), Endocrinology, Diabetes and Metabolism (645 citations), Biological Psychiatry (76 citations) and Behavioral Neuroscience (75 citations). Jun Iwanami has collaborated with scholars based in Japan, Sweden and Germany. Frequent co-authors include Masatsugu Horiuchi, Masaki Mogi, Li‐Juan Min, Kana Tsukuda, Masaru Iwai, Akiko Sakata, Jian‐Mei Li, Fei Jing, Kousei Ohshima and Harumi Kan‐no. Their work appears in journals such as Hypertension, Hypertension Research, PLoS ONE, Journal of the American Society of Hypertension and American Journal of Hypertension.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact